Quantcast

Latest Solifenacin Stories

2011-05-17 14:31:00

DEERFIELD, Ill., May 17, 2011 /PRNewswire/ -- Astellas Pharma US, Inc. ("Astellas Pharma US"), U.S. subsidiary of Astellas Pharma Inc. (Tokyo: TSE: 4503, "the Company"), today announced the results of a pivotal phase III clinical trial for mirabegron, the first of a new class of compounds under development for the treatment of overactive bladder (OAB), which show mirabegron significantly improves key OAB symptoms - urinary incontinence (leakage of urine) and frequency of micturition...

2011-03-22 09:36:00

TOKYO, March 22, 2011 /PRNewswire-FirstCall/ -- Astellas Pharma Inc.(TSE:4503,"Astellas") ( http://www.astellas.com/en/corporate/) today announced the results of two pivotal phase III clinical trials for mirabegron, the first of a new class of compounds under development for the treatment of overactive bladder (OAB), show mirabegron significantly improves key OAB symptoms - urinary incontinence and frequency of micturition[1,2]. These data were presented for the first time this week at...

2009-04-30 05:59:00

Canadian study (VECTOR) presented at the 2009 American Urological Association Annual Meeting CHICAGO, April 30 /PRNewswire/ - Patients with overactive bladder (OAB) treated with solifenacin reported significantly lower incidence and severity of dry mouth, an often intolerable anti-cholinergic side effect, than those treated with oxybutynin immediate-release (IR). This was one of the key findings contained in the VECTOR (VEsicare in Comparison To Oxybutynin for oveRactive bladder...

2008-10-31 15:00:10

Pfizer Inc said today that the U.S. Food and Drug Administration (FDA) approved TOVIAZ(TM) (fesoterodine fumarate) extended release tablets for the treatment of overactive bladder (OAB) symptoms. New once-daily TOVIAZ can significantly reduce the number of urge urinary incontinence episodes and the frequency of urination over 24 hours, symptoms of OAB that can significantly impact patients' lives. Overactive bladder is a bothersome medical condition that affects an estimated one in six...

2008-07-11 09:01:07

Q: You mentioned several types of medications that increase the risk of hyperthermia during hot weather. Would you provide a detailed list? A: Hot weather can cause the body to overheat, called hyperthermia. The evaporation of sweat is the body's primary way of cooling off. Numerous medications impair the body's ability to sweat and so boost the risk for heat exhaustion and heat stroke, conditions covered in a recent column. The chief culprits are drugs with anticholinergic effects,...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'